Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Vivo Bio Tech Ltd has informed the stock exchanges that its trading window for securities will remain closed for all insiders, designated persons, and their immediate relatives starting April 1, 2026. The window will stay shut until 48 hours after the company declares its audited standalone and consolidated financial results for the fourth quarter and full year ended March 31, 2026. This is a routine compliance requirement under SEBI's Insider Trading Regulations, 2015. The filing was signed by Company Secretary A V Kiran. No actual insider trades are reported in this filing.
This is a standard regulatory disclosure with no direct impact on the stock price. It simply means company insiders cannot buy or sell shares until earnings are announced, which signals that Q4 and FY26 results are due soon.